Strategies to improve pharmacogenomic-guided treatment options for patients with β-hemoglobinopathies.

Authors :: Patrinos GP
Chui DHK
Hardison RC
Steinberg MH
Source :: Expert review of hematology [Expert Rev Hematol] 2021 Oct; Vol. 14 (10), pp. 883-885. Date of Electronic Publication: 2021 Sep 08.
Publication Year :: 2021

Subjects :: Humans
Hydroxyurea
Pharmacogenetics
Anemia, Sickle Cell
Hemoglobinopathies drug therapy
Hemoglobinopathies genetics
beta-Thalassemia drug therapy
beta-Thalassemia genetics

Full Text Access

Tools